Stocks
GlaxoSmithKline (GSK) Net margin US GAAP (year values) |
|||||||||
| 2022 | 2023 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| Net margin, % | ? | 16.8% | 16.2% | 16.2% | 8.21% | 17.5% | 17.8% | ||
| Changes by years, y/y, % | -34pp | -1pp | 0pp | -8pp | +9pp | +0.7% | |||
GlaxoSmithKline. Net margin, %
GlaxoSmithKline. Net margin, changes, pp
GlaxoSmithKline (GSK) Net margin US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| Net margin, % | ? | 21.6% | 18.1% | 23.6% | 7.38% | 22.8% | 17.8% | |
| Changes by years, y/y, % | +7pp | +3pp | +24pp | +2pp | +1pp | |||
| Changes by quarters, q/q, % | +17pp | -4pp | +5pp | -16pp | +15pp | |||
